ResultsIQ › Latest results › Manipal Health Enterprises Limited
Manipal Health Enterprises Limited Q1 FY27 results deck summary
NSE: MANIPALHOS · BSE: 544847
Results deck of 20 Aug 2026, summarised by AI from the filing.
EBITDA margin fell 230 bps YoY to 24.2% and PAT margin fell 350 bps to 7.9%.
Key takeaways
- Margin decline EBITDA margin fell 230 bps YoY to 24.2% and PAT margin fell 350 bps to 7.9%.
- CONGO-R specialties Gross inpatient revenue from CONGO-R specialties grew 45% YoY, with oncology up 62% and orthopedics up 49%.
- Net debt Net debt ₹8,435 cr with net debt/EBITDA of 2.82x after the Sahyadri acquisition NCD.
Manipal Health Enterprises Limited Q1 FY27 results
As filed: Revenue ₹3,091 cr, EBITDA ₹737 cr, PAT ₹243 cr, EBITDA margin 23.8%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹3,091 cr). Scored once a year-earlier consolidated quarter exists.
Manipal Health Enterprises Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.